Autistic Disorder Pipeline Insight Report 2024, Featuring Key Products Tasimelteon, Cariprazine, L1-79, JZP541, AB-2004, RO6953958 and SB-121
April 22, 2024 11:10 ET
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Autistic Disorder - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive...
Narcolepsy Drugs Industry Outlook to 2030: Emphasizing Growth in the Sodium Oxybate and Central Nervous System Stimulants Segments
January 24, 2024 14:35 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market (By Therapeutic Type, Disease Type, End User, Regional Analysis), Pipeline Analysis, Key Company Profiles and Recent...
Sodium Oxybate Takes Center Stage in Narcolepsy Treatment: Key Player in $5.95 Billion Narcolepsy Drugs Industry by 2030
November 07, 2023 06:48 ET
|
Research and Markets
Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The "Narcolepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has...
Panic Disorder Market Towards US$ 12,621.61 Mn By 2030, A Comprehensive Analysis By Reports Insights
May 29, 2023 05:00 ET
|
REPORTSINSIGHTS CONSULTING PVT LTD
New York, May 29, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Reports Insights, the panic disorder market is poised for strong expansion and is expected to reach USD 12,621.61 Million...
Global Acute Migraine Drugs Market Report 2023: A $14.06 Billion Market by 2028 Featuring Key Players - Eli Lilly and Co, GSK, Bayer, J&J, Teva, AbbVie, Novartis, Merck, Pfizer, & Boehringer Ingelheim
March 10, 2023 05:53 ET
|
Research and Markets
Dublin, March 10, 2023 (GLOBE NEWSWIRE) -- The "Global Acute Migraine Drugs Market - Analysis By Drug Type (Ergot Alkaloids, Analgesics, Triptans, Others), Route of Administration, Availability, By...
The Worldwide Narcolepsy Therapeutics Industry is Projected to Reach $3.6 Billion by 2030 at a CAGR of 7.3%
February 16, 2023 11:33 ET
|
Research and Markets
Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Narcolepsy Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Narcolepsy...
Autism Spectrum Disorder Treatment Global Market Report 2022: Sector to Grow by 6.47% Annually Through 2033
December 29, 2022 07:08 ET
|
Research and Markets
Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Autism Spectrum Disorder Treatment Market by Treatment, Application, Distribution Channel, and by Region - Global Forecast to 2022-2033" report has...
Global Narcolepsy Therapeutics Market Report to 2028: Growing Healthcare Expenditures and Increasing Prevalence of Neurological Conditions are Driving Factors
November 10, 2022 07:08 ET
|
Research and Markets
Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin...
Global Narcolepsy Drugs Market Report 2022 - Sodium Oxybate Dominates, Owing to Its Dual-Pronged Approach in Treating Daytime Extreme Sleepless and Cataplexy
February 28, 2022 05:28 ET
|
Research and Markets
Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been...
Global Narcolepsy Drugs Market (2021 to 2026) - Growth Trends and Forecasts
January 19, 2022 05:13 ET
|
Research and Markets
Dublin, Jan. 19, 2022 (GLOBE NEWSWIRE) -- The "Narcolepsy Drugs Market - Global Industry Analysis (2018 - 2020) - Growth Trends and Market Forecast (2021 - 2026)" report has been added to...